A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma

Eur J Cancer Clin Oncol. 1989 May;25(5):911-2. doi: 10.1016/0277-5379(89)90141-7.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Doxorubicin / administration & dosage
  • Drug Evaluation
  • Female
  • Humans
  • Ifosfamide / administration & dosage
  • Male
  • Mesna / administration & dosage
  • Mesothelioma / drug therapy*
  • Middle Aged
  • Pleural Neoplasms / drug therapy

Substances

  • Doxorubicin
  • Mesna
  • Ifosfamide